Efficacy of diphenhydramine in the prevention of vertigo and nausea at 7 T MRI.

PURPOSE In this study the potential of diphenhydramine in reducing respectively preventing vertigo and nausea induced by the ultra-high static magnetic field at 7 T was evaluated. MATERIALS AND METHODS In a prospective, double blinded, placebo controlled, cross-over randomized study the sensations of 34 volunteers before, during and after exposure to the static magnetic field with and without drug respectively placebo administration were quantified. Fast table motion was applied to increase the incidence of otherwise sparse reports of field related sensations. RESULTS The strength of vertigo can be reduced by the application of diphenhydramine. CONCLUSION Diphenhydramine, even at a low dose, reduces the strength of vertigo at ultra-high static magnetic fields, may be used preventively, and could pave the way to even higher field strength.

[1]  R. Bowtell,et al.  Magnetic‐field‐induced vertigo: A theoretical and experimental investigation , 2007, Bioelectromagnetics.

[2]  B Stoeckel,et al.  [3 Tesla MRI: successful results with higher field strengths]. , 2004, Der Radiologe.

[3]  P. Schmalbrock,et al.  Electromagnetic perspective on the operation of RF coils at 1.5–11.7 Tesla , 2005, Magnetic resonance in medicine.

[4]  F. Gengo,et al.  The pharmacodynamics of diphenhydramine‐induced drowsiness and changes in mental performance , 1989, Clinical pharmacology and therapeutics.

[5]  Oliver Kraff,et al.  Subjective acceptance of 7 Tesla MRI for human imaging , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.

[6]  C. Wood,et al.  Comparison of efficacy of ginger with various antimotion sickness drugs. , 1988, Clinical research practices and drug regulatory affairs.

[7]  C. Wood,et al.  Effects of ginger on motion sickness susceptibility and gastric function. , 1991, Pharmacology.

[8]  D. Greenblatt,et al.  Pharmacokinetics and Pharmacodynamics of Diphenhydramine 25 mg in Young and Elderly Volunteers , 1998, Journal of clinical pharmacology.

[9]  M. Frosini,et al.  Pharmacokinetics of diphenhydramine in healthy volunteers with a dimenhydrinate 25 mg chewing gum formulation. , 2003, Methods and findings in experimental and clinical pharmacology.

[10]  F. Estelle,et al.  H1-receptor antagonists: safety issues. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  L. Quettier,et al.  The Whole Body 11.7 T MRI Magnet for Iseult/INUMAC Project , 2008, IEEE Transactions on Applied Superconductivity.

[12]  Peter Andersen,et al.  9.4T human MRI: Preliminary results , 2006, Magnetic resonance in medicine.

[13]  P. Brédy,et al.  Iseult/INUMAC Whole Body 11.7 T MRI Magnet Status , 2010, IEEE Transactions on Applied Superconductivity.

[14]  A. Heerschap,et al.  Proton spectroscopic imaging of the human prostate at 7 T , 2009, NMR in biomedicine.

[15]  Oliver Speck,et al.  Retinotopic mapping of the human visual cortex at a magnetic field strength of 7T , 2009, Clinical Neurophysiology.

[16]  M. Knopp,et al.  Klinische Hoch- und Ultrahochfeld-MR und ihre Wechselwirkung mit biologischen Systemen , 2003, Der Radiologe.

[17]  M. Ladd,et al.  Imaging of patients with hippocampal sclerosis at 7 Tesla: initial results. , 2010, Academic radiology.

[18]  C L Dumoulin,et al.  Human exposure to 4.0-Tesla magnetic fields in a whole-body scanner. , 1992, Medical physics.